| MC4R |
MC4R: Melanocortin receptor 4 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.978 |
Evidence |
|
| MC4R |
MC4R: Melanocortin receptor 4 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.978 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.978 |
Evidence |
|
| SERPINB4 |
SERPINB3, SCCA, SCCA1: Serpin B3 |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
0.978 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
BMX |
IPI00514142 |
0.978 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.978 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.978 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.978 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.978 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
0.978 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
0.978 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
0.978 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.978 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.978 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.978 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.978 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.978 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.978 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
0.978 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
0.978 |
Evidence |
|
| IFNAR1 |
IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor |
IL22 |
IL22, ILTIF, UNQ3099/PRO10096: Interleukin-22 precursor |
0.978 |
Evidence |
|
| PRLR |
PRLR: Prolactin receptor precursor |
IL2 |
IL2: Interleukin 2 |
0.978 |
Evidence |
|
| MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
ATF1 |
ATF1: Cyclic AMP-dependent transcription factor ATF-1 |
0.978 |
Evidence |
|
| ITGB4 |
IPI00027422 |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
0.978 |
Evidence |
|
| ITGB4 |
IPI00027422 |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
0.978 |
Evidence |
|